• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征亚型的短期稳定性:采用 Rome III 分类的前瞻性评估。

Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.

机构信息

Department of Medicine, Køge Hospital, University of Copenhagen, Denmark.

出版信息

Aliment Pharmacol Ther. 2012 Feb;35(3):350-9. doi: 10.1111/j.1365-2036.2011.04948.x. Epub 2011 Dec 18.

DOI:10.1111/j.1365-2036.2011.04948.x
PMID:22176384
Abstract

BACKGROUND

In irritable bowel syndrome (IBS) subtyping is used in research and clinical practice. Knowledge of subtype stability is needed for proper design of trials and treatment strategies.

AIMS

To evaluate the stability of Rome III IBS subtypes over time and to determine the optimal time period for prospective, diary-based subtyping.

METHODS

Rome III IBS patients aged 18-70 years enrolled in two identical, randomised, placebo-controlled trials of probiotics, were included. No difference was found on stool pattern, thus patients were analysed as one group. Patients scored defaecations according to Bristol Stool Form Scale for 10 weeks. IBS subtypes were determined for all 1- and 2-week periods. Subtype distribution and stool pattern over time were determined. The proportions of patients having the same subtype all weeks (stable patients) or having a predominant subtype (same subtype ≥60% of time) were determined.

RESULTS

A total of 126 patients, mean age 46 ± 15 years, 72% women were included. Subtype distribution was similar over time with IBS with constipation, IBS with diarrhoea and IBS unsubtyped constituting one-third of the population each. Even though only 18-35% had the same subtype all weeks, the majority of patients had the same subtype for ≥60% of time (82-98%). Sixty-nine per cent had the same predominant and baseline subtypes. Two-week data increased the proportion of stable patients, of patients with a predominant subtype, and of patients who had similar baseline and predominant subtype.

CONCLUSIONS

Most IBS patients change subtype over time. However, an underlying stool pattern stability was demonstrated in the majority of patients. To increase stability, we recommend 2-week data for IBS subtyping.

摘要

背景

在肠易激综合征(IBS)亚型分类中,在研究和临床实践中都有应用。为了正确设计试验和治疗策略,需要了解亚型的稳定性。

目的

评估罗马 III IBS 亚型随时间的稳定性,并确定前瞻性、基于日记的亚型分类的最佳时间间隔。

方法

纳入了年龄在 18-70 岁的罗马 III IBS 患者,他们参加了两项相同的、随机的、安慰剂对照的益生菌临床试验。由于粪便模式没有差异,因此将患者作为一个组进行分析。患者根据布里斯托粪便形态量表记录 10 周的排便情况。对所有 1 周和 2 周的时间段进行 IBS 亚型的确定。确定了随时间变化的亚型分布和粪便模式。确定了所有周都具有相同亚型的患者(稳定患者)或具有主要亚型(相同亚型占时间的≥60%)的比例。

结果

共纳入了 126 名患者,平均年龄 46±15 岁,72%为女性。随着时间的推移,亚型分布相似,其中便秘型 IBS、腹泻型 IBS 和未分型 IBS 各占三分之一。尽管只有 18-35%的患者所有周都具有相同的亚型,但大多数患者在≥60%的时间内具有相同的亚型(82-98%)。69%的患者具有相同的主要和基线亚型。两周的数据增加了稳定患者的比例、具有主要亚型的患者的比例以及具有相似基线和主要亚型的患者的比例。

结论

大多数 IBS 患者随时间改变亚型。然而,大多数患者显示出潜在的粪便模式稳定性。为了提高稳定性,我们建议使用 2 周的数据进行 IBS 亚型分类。

相似文献

1
Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.肠易激综合征亚型的短期稳定性:采用 Rome III 分类的前瞻性评估。
Aliment Pharmacol Ther. 2012 Feb;35(3):350-9. doi: 10.1111/j.1365-2036.2011.04948.x. Epub 2011 Dec 18.
2
Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.根据主要排便习惯对肠易激综合征进行亚型分类:罗马II标准与罗马III标准对比
Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61. doi: 10.1111/j.1365-2036.2007.03422.x.
3
Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.罗马 III 标准下的肠易激综合征亚型:一项多中心研究。
J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x.
4
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).肠易激综合征患者肠道习惯随时间的变化:一项前瞻性观察性1年随访研究(RITMO研究)
Aliment Pharmacol Ther. 2007 Feb 1;25(3):323-32. doi: 10.1111/j.1365-2036.2006.03197.x. Epub 2007 Jan 8.
5
Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.水媒病毒性肠胃炎爆发后感染后肠易激综合征和功能性肠紊乱的发病率。
Am J Gastroenterol. 2012 Jun;107(6):891-9. doi: 10.1038/ajg.2012.102. Epub 2012 Apr 24.
6
Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.腹泻在评估肠易激综合征临床研究中便秘的重要性。
J Clin Gastroenterol. 2011 Oct;45(9):790-3. doi: 10.1097/MCG.0b013e3182053cea.
7
Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up.儿童肠易激综合征亚型:诊断时和随访时的患病率。
J Pediatr. 2014 May;164(5):1099-1103.e1. doi: 10.1016/j.jpeds.2013.12.043. Epub 2014 Jan 31.
8
Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.肠易激综合征患者交替性排便习惯亚型的特征分析
Am J Gastroenterol. 2005 Apr;100(4):896-904. doi: 10.1111/j.1572-0241.2005.41211.x.
9
Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.罗马 III 标准中肠易激综合征患者急性疼痛发作的特征。
Am J Gastroenterol. 2011 Jul;106(7):1299-307. doi: 10.1038/ajg.2011.78. Epub 2011 Mar 29.
10
Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.贝得石蒙脱石对肠易激综合征的症状疗效:一项随机对照试验
Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44. doi: 10.1111/j.1365-2036.2005.02330.x.

引用本文的文献

1
Strategies for Producing Low FODMAPs Foodstuffs: Challenges and Perspectives.生产低聚果糖食品的策略:挑战与展望
Foods. 2023 Feb 17;12(4):856. doi: 10.3390/foods12040856.
2
The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis.维生素 D 补充剂治疗肠易激综合征的疗效:系统评价与荟萃分析。
Nutr J. 2022 May 5;21(1):24. doi: 10.1186/s12937-022-00777-x.
3
Mill. extract improves symptoms in IBS patients with diarrhoea: post hoc analysis of two randomized double-blind controlled studies.
毫提取物可改善腹泻型肠易激综合征患者症状:两项随机双盲对照研究的事后分析
Therap Adv Gastroenterol. 2021 Oct 8;14:17562848211048133. doi: 10.1177/17562848211048133. eCollection 2021.
4
Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.腹痛的表现和特征因肠易激综合征亚型而异:一项全国性基于人群的研究结果。
Am J Gastroenterol. 2020 Feb;115(2):294-301. doi: 10.14309/ajg.0000000000000502.
5
Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients.认知行为疗法联合运动干预对腹泻型肠易激综合征患者认知偏差及应对方式的影响
World J Clin Cases. 2019 Nov 6;7(21):3446-3462. doi: 10.12998/wjcc.v7.i21.3446.
6
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome.肠道真菌群在肠易激综合征中的潜在作用
Front Microbiol. 2019 Aug 21;10:1894. doi: 10.3389/fmicb.2019.01894. eCollection 2019.
7
Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.中重度便秘型肠易激综合征在六个欧洲国家的经济负担。
BMC Gastroenterol. 2019 May 7;19(1):69. doi: 10.1186/s12876-019-0985-1.
8
Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study.关节过度活动综合征对肠易激综合征患者低可发酵寡糖、双糖、单糖和多元醇饮食反应的影响:一项回顾性研究
Gastroenterology Res. 2019 Feb;12(1):27-36. doi: 10.14740/gr1133. Epub 2019 Feb 26.
9
Effect of GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome.感染后肠易激综合征大鼠 GG 上清液对 5-羟色胺转运体表达的影响。
World J Gastroenterol. 2018 Jan 21;24(3):338-350. doi: 10.3748/wjg.v24.i3.338.
10
Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.肠易激综合征各亚型中抗纽蛋白和抗细胞致死性扩张毒素B抗体的评估
Dig Dis Sci. 2017 Jun;62(6):1480-1485. doi: 10.1007/s10620-017-4585-z. Epub 2017 Apr 27.